Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
13,625.00    95.00 (0.70%)
Bid:
13,580.00
Ask:
13,590.00
Spread: 10.00 (0.074%)
Market Cap: £15.55b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

Trading Statement

2 Nov 2022 07:00

RNS Number : 9956E
Next PLC
02 November 2022
 

Trading Statement - 2 November 2022

HEADLINES

· In the thirteen weeks to 29 October full price sales1 were up +0.4%2 versus last year. This was slightly ahead of our expectations.

· We are maintaining our guidance for full year profit before tax at £840m, up +2.1% versus last year. Based on this profit guidance, Earnings Per Share of 554.5p would be up +4.5% versus last year. 

 

1 Full price sales are total sales excluding VAT, less items sold in our Sale events, our Clearance operations and through Total Platform. These are not statutory sales. 

2 Full price sales excluding Russia and Ukraine were up +1.5%.

 

FULL PRICE SALES GROWTH BY WEEK

Our week by week full price sales performance is set out in the chart below. The grey bars are the five weeks since our last trading update, given in our Half Year Results in September. Full price sales in the last five weeks have been up +1.4%, boosted by one particularly strong week at the end of September, when temperatures dropped and sales of heavier weight products improved.

Click or paste the following link into your web browser to view the chart titled 2022 Full Price Sales Variance by Week Versus 2021. Refer to page 1 for this chart. http://www.rns-pdf.londonstockexchange.com/rns/9956E_1-2022-11-1.pdf

 

Q3 FULL PRICE SALES PERFORMANCE BY BUSINESS CHANNEL

Full price sales (VAT exclusive) by division versus last year

Q3 to 29 October

Online

- 1.9%

Retail (UK and Ireland)

+3.1%

Total Product full price sales

- 0.1%

Finance interest income

+8.9%

Total full price sales including interest income

+0.4%

 

FULL PRICE SALES GROWTH BY MONTH AND REST OF YEAR FORECAST

We are maintaining our previous guidance for full price sales for the rest of the year to be down -2% versus last year. 

Click or paste the following link into your web browser to view the chart titled Q3 Full Price Sales Performed by Month and Q4 Forecast. Refer to page 2 for this chart. http://www.rns-pdf.londonstockexchange.com/rns/9956E_1-2022-11-1.pdf

 

GUIDANCE FOR FULL PRICE SALES, PROFIT & EPS

Our guidance for sales and profit remains unchanged and is set out in the table below. The difference in the growth in Earnings Per Share and profit before tax is due to share buybacks completed since January 2022. 

Guidance for 2022/23

Latest guidance

Rest of year full price sales growth

- 2%

Profit before tax

£840m

Profit before tax versus 2021/22

+2.1%

Earnings Per Share

554.5p

Earnings Per Share versus 2021/22

+4.5%

CHRISTMAS TRADING STATEMENT

We intend to give an update on sales to Saturday 31 December on Thursday 5 January 2023. 

Note for Analysts Concerning EPS Comparison with September Guidance

In our September guidance, the boost to EPS from share buybacks was largely offset by an expected decrease in the value of our deferred tax asset. This was caused by the proposed reduction in the future Corporation Tax rate as announced in the September mini-budget. Now that decision has been reversed by the Government, the value of our deferred tax asset will not be reduced so we anticipate getting the full benefit of EPS enhancement from share buybacks in the year.

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

 

Date:

Embargoed until 07:00 hrs, Wednesday 2 November 2022

Contacts:

Amanda James, Group Finance Director (analyst calls)

Tel: 0333 777 8888

Alistair Mackinnon-Musson, Rowbell PR

Tel: 020 7717 5239

Photographs:

https://www.nextplc.co.uk/media/image-gallery/campaign-images

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFLLBLFLLFBZ
Date   Source Headline
16th Jan 20267:00 amRNSRedemption of B Shares
15th Jan 20266:20 pmRNSIssue of B Shares
15th Jan 202611:48 amRNSResult of Meeting
9th Jan 20267:00 amRNSDirectorate Change
6th Jan 20267:00 amRNSTrading Statement
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20257:00 amRNSCircular and Notice of General Meeting
19th Dec 20257:00 amRNSCircular and Notice of General Meeting
1st Dec 202512:58 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSSale of land at Waltham Abbey
14th Nov 20254:05 pmRNSAGM Update
3rd Nov 20257:00 amRNSTotal Voting Rights
30th Oct 202510:29 amRNSDirector/PDMR Shareholding
29th Oct 20257:00 amRNSTrading Statement
17th Oct 20253:36 pmRNSDirector/PDMR Shareholding
6th Oct 20255:04 pmRNSHolding(s) in Company
3rd Oct 20254:45 pmRNSDirector/PDMR Shareholding
1st Oct 20252:40 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSTotal Voting Rights
30th Sep 20254:27 pmRNSDirector/PDMR Shareholding
19th Sep 20255:06 pmRNSTransaction in Own Shares
19th Sep 202510:47 amRNSDirector/PDMR Shareholding
18th Sep 20255:26 pmRNSTransaction in Own Shares
18th Sep 20257:00 amRNSResults for the Half Year Ended July 2025
15th Sep 20259:31 amRNSHolding(s) in Company
3rd Sep 20255:20 pmRNSTransaction in Own Shares
2nd Sep 20255:38 pmRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTotal Voting Rights
18th Aug 20255:25 pmRNSNon-discretionary Share Repurchase Programme
18th Aug 20255:20 pmRNSTransaction in Own Shares
15th Aug 20255:11 pmRNSTransaction in Own Shares
14th Aug 20255:21 pmRNSTransaction in Own Shares
13th Aug 20255:43 pmRNSTransaction in Own Shares
12th Aug 20255:24 pmRNSTransaction in Own Shares
11th Aug 20255:19 pmRNSTransaction in Own Shares
4th Aug 20259:52 amRNSResult of Audit Tender
1st Aug 20258:34 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSTrading Statement
18th Jul 20252:17 pmRNSUpdate on Outstanding Notes and RCF
16th Jul 202512:37 pmRNSFinal Results of Tender Offer
16th Jul 20258:47 amRNSIndicative Results of Tender Offer
7th Jul 20258:42 amRNSTender Offer
1st Jul 20257:00 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTotal Voting Rights
15th May 20253:38 pmRNSResult of AGM
9th May 20252:58 pmRNSDirector/PDMR Shareholding
8th May 20257:00 amRNSTrading Statement
1st May 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.